| Authors: |
Hamadeh IS; Memorial Sloan Kettering Cancer Center, Clinical Pharmacy Services, New York, NY., Merz M; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY., Derkach A; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY., Modelevsky L; Memorial Sloan Kettering Cancer Center, Clinical Pharmacy Services, New York, NY., Lesokhin AM; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY., Mailankody S; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY., Hultcrantz ML; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY., Tan CR; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY., Hassoun H; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY., Shah UA; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY., Maclachlan K; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY., Rajeeve S; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY., Hashmi H; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY., Maura F; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY., Firestone RS; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY., Wang AX; Memorial Sloan Kettering Cancer Center, Clinical Pharmacy Services, New York, NY., Amin A; Memorial Sloan Kettering Cancer Center, Clinical Pharmacy Services, New York, NY., Patel D; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY., Scordo M; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Transplant and Cellular Therapy Services, New York, NY., Shah GL; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Transplant and Cellular Therapy Services, New York, NY., Landau HJ; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Transplant and Cellular Therapy Services, New York, NY., Giralt S; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Transplant and Cellular Therapy Services, New York, NY., Usmani SZ; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY., Korde N; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY. Electronic address: korden@mskcc.org. |
